Differential (Click to cross reference) adverse drug reaction apomorphine aspartate aminotransferase catechol-o-methyltransferase inhibitor diarrhea drug interactions dyskinesia entacapone enzyme inhibition enzyme, serum hepatic failure L-dopa L-dopa, drug interactions with and side effects of liver function enzymes mortality neuroleptic malignant syndrome Parkinson disease Parkinson disease, fluctuations in Parkinson disease, on-off phenomena in Parkinson disease, treatment of Parkinson disease, wearing off review article serum alanine aminotransferase serum glutamic oxaloacetic transaminase serum glutamic pyruvic transaminase sinemet tolcapone treatment of neurologic disorder

Showing articles 0 to 8 of 8 Tolcapone and Hepatotoxic Effects Arch Neurol 57:263-267, Olanow,C.W.&Tasmar Advisory Panel, 2000 Tolcapone for Parkinson's Disease The Medical Letter 40:60-61, , 1998 Random, Placebo-Contr Study of Tolcapone in Pts with Fluctuating Parkinson Dis Trtd With Levodopa-Carbidopa Arch Neurol 55:1089-1095, Adler,C.H.,et al, 1998 Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease Lancet 351:1221-1222, Nutt,J.G., 1998 Tasmar (tolcapone) Labeling Revisions of Package Insert Roche Laboratories, , 1998 Tolcapone in Stable Parkinson's Disease:Efficacy and Safety of Long-Term Treatment Neurol 49:665-671, Waters,C.H.,et al, 1997 COMT Inhibition with Tolcapone Reduces the"Wearing Off"Phenomenon & Levodopa Requirements in Fluctuating Parkinsonisn Pts JNNP 63:421-428, Baas,H.,et al, 1997 Tolcapone Improves Motor Function in Parkinsonian Pts with the"Wearing Off"Phenomenon Neurol 49:1066-1071, Rajput,A.H.,et al, 1997 Showing articles 0 to 8 of 8